Positron Opens Pharmaceutical Facility in Indiana
08/10/2010
"While the company's plan is to focus on small batch, radioactive PET products, the facility will also be utilized to support current and future Positron equipment, as well as, expand into new markets," said John Zehner, Positron COO.
The approximately 10,000-square-foot facility has room for the company to expand, and includes a clean room and laboratory to produce pharmaceuticals for industrial and medical applications. All products made at the Indiana facility will meet or exceed Food and Drug Administration (FDA) requirements.
Project Announcements
Eurofins Lancaster Laboratories Expands Lancaster County, Research Operations
01/03/2026
Valerie Health Plans Chattanooga, Tennessee, Operations
01/02/2026
Samsung Biologics Plans Rockville, Maryland, Manufacturing Operations
12/31/2025
SencorpWhite Plans Hamilton, Ohio, Headquarters-Manufacturing Operations
12/29/2025
Kraken Technologies Limited Plans New York City Headquarters Operations
12/29/2025
Lupin Expands Coral Springs, Florida, Operations
12/29/2025
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
America’s Aerospace Reboot
Q3 2025